CCM
Consonance Capital Management Portfolio holdings
AUM
$7.28M
1-Year Return
42.86%
This Quarter Return
+17.71%
1 Year Return
-42.86%
3 Year Return
+319.33%
5 Year Return
+899.35%
10 Year Return
–
AUM
$1.55B
AUM Growth
+$456M
(+42%)
Cap. Flow
+$335M
Cap. Flow
% of AUM
21.59%
Top 10 Holdings %
Top 10 Hldgs %
61.57%
Holding
33
New
7
Increased
11
Reduced
3
Closed
4
Top Buys
| 1 |
Puma Biotechnology
PBYI
|
$124M |
| 2 |
Karyopharm Therapeutics
KPTI
|
$81M |
| 3 |
NVRO
NEVRO CORP.
NVRO
|
$75.3M |
| 4 |
Exelixis
EXEL
|
$69.1M |
| 5 |
Verastem
VSTM
|
$49.3M |
Top Sells
| 1 |
RDUS
Radius Health, Inc.
RDUS
|
$104M |
| 2 |
Iovance Biotherapeutics
IOVA
|
$54.2M |
| 3 |
AMRN
Amarin Corp
AMRN
|
$39.4M |
| 4 |
Dynavax Technologies
DVAX
|
$32.9M |
| 5 |
Corcept Therapeutics
CORT
|
$8.8M |
Sector Composition
| 1 | Healthcare | 99.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RARX
26
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $14.5M | 0.93% |
1,454,761
| – | – |
|
|
CSII
27
DELISTED
Cardiovascular Systems, Inc.
CSII
| $9.87M | 0.64% |
305,235
-140,865
| -32% | -$4.56M |
|
28
ANI Pharmaceuticals
ANIP
$2.07B
| $9.55M | 0.62% |
142,943
| – | – |
|
|
FLXN
29
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $5.62M | 0.36% |
217,392
+10,000
| +5% | +$259K |
|
|
30
Dynavax Technologies
DVAX
$1.18B
| – | – |
-1,658,795
| Closed | -$32.9M |
|
|
31
Iovance Biotherapeutics
IOVA
$901M
| – | – |
-3,206,073
| Closed | -$54.2M |
|
|
RDUS
32
DELISTED
Radius Health, Inc.
RDUS
| – | – |
-2,900,893
| Closed | -$104M |
|
|
CVRS
33
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
| – | – |
-4,574,835
| Closed | -$6.27M |
|